Baidu
map

阿奇霉素:四种情况不能使用 !

2016-05-12 佚名 药评中心

阿奇霉素被广泛地运用于临床,一方面,在支原体感染所致的性传播疾病中,阿奇霉素是很有效的药物;另一方面,一日一次,一次0.25g,连服5日,患者依从性高;再者,作为一种大环内酯类抗生素,阿奇霉素的副作用轻微。 然而,最近的研究结果显示,与未服用抗生素的患者相比,阿奇霉素5日疗法死亡风险显著增加(心血管死亡风险HR:2.88;其他原因致死风险HR:1.85)。与阿莫西林相比,阿奇霉素服用者心

阿奇霉素被广泛地运用于临床,一方面,在支原体感染所致的性传播疾病中,阿奇霉素是很有效的药物;另一方面,一日一次,一次0.25g,连服5日,患者依从性高;再者,作为一种大环内酯类抗生素,阿奇霉素的副作用轻微。
 
然而,最近的研究结果显示,与未服用抗生素的患者相比,阿奇霉素5日疗法死亡风险显著增加(心血管死亡风险HR:2.88;其他原因致死风险HR:1.85)。与阿莫西林相比,阿奇霉素服用者心血管死亡风险亦明显升高,且在心血管疾病高危患者中最为显著。
 
如何更加合理用好阿奇霉素,以避免致命性心律失常的风险?对此,美国FDA提出了如下建议:
 
1.确诊的QT间期延长,先天性长QT间期综合征,尖端扭转型室速病史,心动过缓,或失代偿性心力衰竭不能使用;
 
2.患者处于促心律失常状态,例如未纠正的低钾血症、低镁血症患者不能使用;
 
3.正在使用延长QT间期药物的患者,比如IA型(丙吡胺、奎尼丁、双氢奎尼丁)和III型(胺碘酮、多非利特、伊布利特、索他洛尔)抗心律失常药物;抗精神病药物;抗抑郁药物;氟喹诺酮类药物(如莫西沙星、左氧氟沙星);其他药物(西沙比利、咪唑斯汀)治疗的患者不能使用;
 
4.老年心脏病患者对影响QT间期的药物更为敏感,所以不能使用。
 
美国FDA同时建议对于存在上述情况的患者,应更换其他抗生素治疗,在选择替代药物时应考虑:喹诺酮类药物与其它大环内酯类药物同样存在QT间期延长的副作用。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=106878, encodeId=53341068e82b, content=深入学习,好文值得点赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Mon Aug 29 14:21:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=95466, encodeId=03cf954668b, content=谢谢,学习到新知识。, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Mon Aug 01 22:03:00 CST 2016, time=2016-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86217, encodeId=8d798621e63, content=学习了抗生素的新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=31721725856, createdName=1ded7dd9m47(暂无匿称), createdTime=Wed May 18 04:01:00 CST 2016, time=2016-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86002, encodeId=61ef8600215, content=学到了,每天增加一点抗生素治疗知识。, beContent=null, objectType=article, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170701/IMG595791009FB761316.jpg, createdBy=abd01695121, createdName=吴教授, createdTime=Mon May 16 16:09:00 CST 2016, time=2016-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85627, encodeId=9ad08562e8d, content=学习了很好的资料, beContent=null, objectType=article, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4bfa83595, createdName=jetleo, createdTime=Fri May 13 00:06:00 CST 2016, time=2016-05-13, status=1, ipAttribution=)]
    2016-08-29 ylzr123

    深入学习,好文值得点赞!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=106878, encodeId=53341068e82b, content=深入学习,好文值得点赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Mon Aug 29 14:21:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=95466, encodeId=03cf954668b, content=谢谢,学习到新知识。, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Mon Aug 01 22:03:00 CST 2016, time=2016-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86217, encodeId=8d798621e63, content=学习了抗生素的新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=31721725856, createdName=1ded7dd9m47(暂无匿称), createdTime=Wed May 18 04:01:00 CST 2016, time=2016-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86002, encodeId=61ef8600215, content=学到了,每天增加一点抗生素治疗知识。, beContent=null, objectType=article, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170701/IMG595791009FB761316.jpg, createdBy=abd01695121, createdName=吴教授, createdTime=Mon May 16 16:09:00 CST 2016, time=2016-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85627, encodeId=9ad08562e8d, content=学习了很好的资料, beContent=null, objectType=article, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4bfa83595, createdName=jetleo, createdTime=Fri May 13 00:06:00 CST 2016, time=2016-05-13, status=1, ipAttribution=)]
    2016-08-01 刘煜

    谢谢,学习到新知识。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=106878, encodeId=53341068e82b, content=深入学习,好文值得点赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Mon Aug 29 14:21:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=95466, encodeId=03cf954668b, content=谢谢,学习到新知识。, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Mon Aug 01 22:03:00 CST 2016, time=2016-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86217, encodeId=8d798621e63, content=学习了抗生素的新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=31721725856, createdName=1ded7dd9m47(暂无匿称), createdTime=Wed May 18 04:01:00 CST 2016, time=2016-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86002, encodeId=61ef8600215, content=学到了,每天增加一点抗生素治疗知识。, beContent=null, objectType=article, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170701/IMG595791009FB761316.jpg, createdBy=abd01695121, createdName=吴教授, createdTime=Mon May 16 16:09:00 CST 2016, time=2016-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85627, encodeId=9ad08562e8d, content=学习了很好的资料, beContent=null, objectType=article, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4bfa83595, createdName=jetleo, createdTime=Fri May 13 00:06:00 CST 2016, time=2016-05-13, status=1, ipAttribution=)]
    2016-05-18 1ded7dd9m47(暂无匿称)

    学习了抗生素的新知识

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=106878, encodeId=53341068e82b, content=深入学习,好文值得点赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Mon Aug 29 14:21:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=95466, encodeId=03cf954668b, content=谢谢,学习到新知识。, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Mon Aug 01 22:03:00 CST 2016, time=2016-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86217, encodeId=8d798621e63, content=学习了抗生素的新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=31721725856, createdName=1ded7dd9m47(暂无匿称), createdTime=Wed May 18 04:01:00 CST 2016, time=2016-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86002, encodeId=61ef8600215, content=学到了,每天增加一点抗生素治疗知识。, beContent=null, objectType=article, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170701/IMG595791009FB761316.jpg, createdBy=abd01695121, createdName=吴教授, createdTime=Mon May 16 16:09:00 CST 2016, time=2016-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85627, encodeId=9ad08562e8d, content=学习了很好的资料, beContent=null, objectType=article, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4bfa83595, createdName=jetleo, createdTime=Fri May 13 00:06:00 CST 2016, time=2016-05-13, status=1, ipAttribution=)]
    2016-05-16 吴教授

    学到了,每天增加一点抗生素治疗知识。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=106878, encodeId=53341068e82b, content=深入学习,好文值得点赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Mon Aug 29 14:21:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=95466, encodeId=03cf954668b, content=谢谢,学习到新知识。, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Mon Aug 01 22:03:00 CST 2016, time=2016-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86217, encodeId=8d798621e63, content=学习了抗生素的新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=31721725856, createdName=1ded7dd9m47(暂无匿称), createdTime=Wed May 18 04:01:00 CST 2016, time=2016-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86002, encodeId=61ef8600215, content=学到了,每天增加一点抗生素治疗知识。, beContent=null, objectType=article, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170701/IMG595791009FB761316.jpg, createdBy=abd01695121, createdName=吴教授, createdTime=Mon May 16 16:09:00 CST 2016, time=2016-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=85627, encodeId=9ad08562e8d, content=学习了很好的资料, beContent=null, objectType=article, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4bfa83595, createdName=jetleo, createdTime=Fri May 13 00:06:00 CST 2016, time=2016-05-13, status=1, ipAttribution=)]
    2016-05-13 jetleo

    学习了很好的资料

    0

相关资讯

NEJM:泌尿生殖道沙眼衣原体感染,阿奇霉素功效不及多西环素

泌尿生殖道沙眼衣原体感染仍然盛行,导致大量的生殖方面的疾病。近年来,阿奇霉素治疗衣原体感染的研究已引起人们的关注。原始出处:William M. Geisler,Apurva Uniyal,Jeannette Y. Lee,et al.Azithromycin versus Doxycycline for Urogenital Chlamydia trachomatis Infection,NEJ

CHEST:阿奇霉素治疗难治性咳嗽效果欠佳

慢性咳嗽是全球常见的临床问题。虽然许多患者有潜在症状,如哮喘,胃食管反流或鼻炎,但即使治疗了这些疾病还是会留下许多疾病症状。这样的患者群都需要新的治疗方法。来自美国的研究人员进行了一项随机,双盲,安慰剂对照试验,以确定每周250mg的阿齐霉素,一周三次,共8周,是否会影响44例治疗性咳嗽患者的莱斯特咳嗽问卷(LCQ)评分。视觉模拟评分法(VAS)和支气管呼出气一氧化氮被用来评估咳嗽严重程度,作为次

JAMA:早期使用阿奇霉素对儿童到底是好是坏?

孩子们经常出现呼吸道感染。大多数孩子仅表现出咳嗽和鼻塞症状且较易恢复,但若疾病发展且愈加严重,则易导致孩子出现呼吸问题,需要紧急就诊。

Obstet Gynecol:ACOG提倡使用双重抗生素治疗淋病

淋球菌对磺酰胺类、四环素、青霉素耐药,因为头孢曲松钠和阿奇霉素是一线治疗药物。在美国淋病是第二个最常见的细菌性性传播疾病,每年估计有 820,000 例新发案例。在2007年,因为淋球菌对氟喹诺酮耐药,疾控中心对淋病的治疗停止推荐氟喹诺酮,使得头孢菌素成为仅存的推荐的抗生素种类。抗生素耐药性产生后会导致治疗的失败、并发症风险增加,以及促进疾病的性传播。ACOG建议头孢曲松钠和阿奇霉素同时使用。对宫

NEJM:单剂量阿奇霉素群体治疗雅司病

雅司病是一种慢性传染病,由梅毒螺旋体的一种亚种导致。这是一种革兰氏阳性菌在遗传学角度与这种非性交传染的地方病雅司病密切相关。雅司病可以通过皮肤伤口的直接接触而传染。阿奇霉素用于群体治疗雅司病世界卫生组织根除雅司病的新策略的中心组成部分。这一全球性计划的实施的首要条件正是证明有效性的实验数据。为此,研究人员开展了此次试验。 研究人员对现有的雅司病进行重复性临床研究,对潜在的雅司病进行血清学

BMJ Open:新生儿使用阿奇霉素的安全性研究

研究者检索了MEDLINE、EMBASE、Pubmed等数据库中关于新生儿使用阿奇霉素的研究,以探究新生儿使用阿奇霉素和不良药物反应。该系统回顾纳入了使用过阿奇霉素的<28天的新生儿,以与阿奇霉素相关的不良事件作为主要结局,而阿奇霉素在新生儿中的使用作为继发结局。最终该系统回顾纳入了11篇相关研究,涉及473名新生儿,数据报道了371例不良事件。不良反应时事件主要包括呼吸系统 (358/1000)

Baidu
map
Baidu
map
Baidu
map